Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection

This publication has 26 references indexed in Scilit:

• Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)
  European Urology, 2022
• La densidad de los ganglios linfáticos en la linfadenectomía retroperitoneal como marcador novel para predecir la recurrencia en pacientes con cáncer testicular de células germinales: estudio de casos y controles y experiencia clínica a largo plazo de un hospital de referencia terciario
  Actas Urológicas Españolas, 2021
• The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer
  Urologic Clinics of North America, 2019
• Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer
  JAMA Otolaryngology–Head & Neck Surgery, 2018
• Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors
  Journal of Urology, 2015
• Retroperitoneal Lymph Node Dissection with No Adjuvant Chemotherapy in Clinical Stage I Nonseminomatous Germ Cell Tumours: Long-Term Outcome and Analysis of Risk Factors of Recurrence
  European Urology, 2010
• The Total Number of Retroperitoneal Lymph Nodes Resected Impacts Clinical Outcome After Chemotherapy for Metastatic Testicular Cancer
  Urology, 2010
• Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer
  Journal of Urology, 2009
• The Will Rogers Phenomenon in Urological Oncology
  Journal of Urology, 2008
• Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy
  European Journal of Cancer, 1995